Foundation Fighting Blindness Retinal Degeneration Fund, Director at Opus Genetics, Inc., sold $7.4M of IRD
This page documents an SEC Form 4 insider trading disclosure for $IRD securities filed with the Securities and Exchange Commission. Section 16 of the Securities Exchange Act of 1934 mandates that corporate officers, directors, and beneficial owners of more than 10% of a company's registered equity securities must report their personal trades within two business days of execution. Insider transactions are closely monitored by market participants because insiders possess firsthand knowledge of company operations, financial condition, and near-term prospects. The transaction details below are drawn directly from the SEC EDGAR filing database and reflect the information as reported.
Transaction Details
| Insider | Foundation Fighting Blindness Retinal Degeneration Fund |
|---|---|
| Title | Director |
| Company | Opus Genetics, Inc. |
| Ticker | IRD |
| Transaction Type | Sale |
| Transaction Date | 2026-05-18 |
| Shares Traded | 1,700,000 |
| Price Per Share | $4.35 |
| Total Value | $7.4M |
| Filed Date | 2026-05-20 |
| Accession Number | 0002042266-26-000001 |
Ownership Context
| Shares Owned After Transaction | 3,792,171 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0002042266-26-000001
Other Insider Trades — IRD
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| YERXA BENJAMIN R | President | sold | $22K | 2026-07-23 |
| Gagnon Robert E. | Chief Financial Officer | sold | $23K | 2026-07-23 |
| Magrath George | Chief Executive Officer | sold | $28K | 2026-07-23 |
| SCHACHLE JOSEPH K | Chief Operating Officer | sold | $14K | 2026-07-23 |
| Zaremba Rabourn Amy | Head of Fin. Quality Assurance | sold | $9K | 2026-04-23 |
| Magrath George | Chief Executive Officer | sold | $50K | 2026-04-23 |
| YERXA BENJAMIN R | President | sold | $39K | 2026-04-23 |
| SCHACHLE JOSEPH K | Chief Operating Officer | sold | $25K | 2026-04-23 |
| Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | sold | $39K | 2026-04-23 |
| Gagnon Robert E. | Chief Financial Officer | sold | $41K | 2026-04-23 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for IRD — Opus Genetics, Inc. →
Whisper Score — IRD
Track IRD insider activity in real time on The Wire →
Get alerts when Foundation Fighting Blindness Retinal Degeneration Fund files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: August 12, 2026 at 07:27 UTC